GH director receives RSUs, company withholds 14,602 shares at $62.48/$62.65
Rhea-AI Filing Summary
Guardant Health director and Co‑Chief Executive Officer AmirAli Talasaz reported multiple transactions in the company's common stock. On 09/30/2025 he received 4,814 shares from vesting of restricted stock units and, separately the same day, 2,440 shares were retained by the company to satisfy tax withholding at a reported price of $62.48. On 10/01/2025 he received an additional 23,997 vested shares and 12,162 shares were retained for tax withholding at $62.65. After these reported transactions his beneficial ownership rose to 2,010,036 shares.
Positive
- Beneficial ownership increased to 2,010,036 shares after reported transactions
- Received vested RSUs totaling 28,811 shares on 09/30/2025 and 10/01/2025 (4,814 + 23,997)
Negative
- Company retained shares for tax withholding totaling 14,602 shares (2,440 + 12,162), reducing net shares delivered
- Retained shares were sold at market prices of $62.48 and $62.65, indicating withholding rather than voluntary sale
Insights
Insider received RSU vesting and retained shares for tax withholding; total holdings increased to 2,010,036.
These entries combine restricted stock unit vesting (codes M) and company retention of shares to cover tax withholding (code F). The filings show vested shares of 4,814 and 23,997 on 09/30/2025 and 10/01/2025, respectively.
This is administrative compensation-related activity rather than open-market purchases or strategic dispositions; retained shares reduced the net received amounts but did not indicate voluntary sale for cash.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 23,997 | $0.00 | -- |
| Exercise | Common Stock | 23,997 | $0.00 | -- |
| Tax Withholding | Common Stock | 12,162 | $62.65 | $762K |
| Exercise | Restricted Stock Units | 4,814 | $0.00 | -- |
| Exercise | Common Stock | 4,814 | $0.00 | -- |
| Tax Withholding | Common Stock | 2,440 | $62.48 | $152K |
Footnotes (1)
- These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025. Not applicable for Restricted Stock Units. This represents a restricted stock unit award granted on March 18, 2024 that vests over a three year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two year period.